Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell mutations may work together to help hide tumors from the immune system, offering a possible way to predict whether the tumors would respond to an emerging class of immunotherapy drugs. The research appears in Cell Reports.

Leave A Comment

Your email address will not be published. Required fields are marked *